Home › Funds › BBR PARTNERS, LLC › ABT

BBR PARTNERS, LLC position in ABT

ABBOTT LABORATORIES · Health Care

BBR PARTNERS, LLC reported holding 53,184 shares of ABT (ABBOTT LABORATORIES) in its Q2 2026 13F filing — a position valued at US$4.8M, representing 0.24% of its reported portfolio and ranking #40 among its reported holdings. BBR PARTNERS, LLC has disclosed ABT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)53.18K sh
Reported value held$4.83M
Portfolio Weight0.24%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BBR PARTNERS, LLC's ABT position evolved

BBR PARTNERS, LLC first disclosed a stake in ABT in Q3 2023 at 50,124 shares (US$4.9M). The position peaked in Q1 2025 at 57,161 shares, worth US$7.6M. Across 12 filings, BBR PARTNERS, LLC increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 53,184 shares valued at US$4.8M — a reduction of -3,191 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 50.12K $4.85M New
Q4 2023 51.43K $5.66M Add
Q1 2024 58.59K $6.66M Add
Q2 2024 49.93K $5.19M Reduce
Q3 2024 60.04K $6.85M Add
Q4 2024 57.20K $6.47M Reduce
Q1 2025 57.16K $7.58M Hold
Q2 2025 54.88K $7.46M Reduce
Q3 2025 54.98K $7.36M Hold
Q4 2025 54.88K $6.88M Hold
Q1 2026 56.38K $5.79M Add
Q2 2026 53.18K $4.83M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has BBR PARTNERS, LLC held ABT?

BBR PARTNERS, LLC has disclosed ABT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is BBR PARTNERS, LLC's current position in ABT?

As of Q2 2026, BBR PARTNERS, LLC holds 53.18K shares of ABT (ABBOTT LABORATORIES), valued at $4.83M, representing 0.24% of its reported portfolio and ranking #40.

Has BBR PARTNERS, LLC been buying or selling ABT?

In the latest 13F filing (Q2 2026), BBR PARTNERS, LLC reduced its position in ABT. The position peaked in Q1 2025 at 57.16K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.